Increasing demand for ART procedure such as egg banking, frozen donor services, and IVF among others, and increasing incidences of infertility are driving ART market revenue growth.
Increasing demand for ART procedure such as egg banking, frozen donor services, and IVF among others, and increasing incidences of infertility are driving ART market revenue growth
The Assisted Reproductive Technology (ART) market size is expected to reach USD 39.12 Billion in 2030 and register a revenue CAGR of 7.4% during the forecast period, according to the latest report by Reports and Data. Increasing demand for surrogacy by the LGBTQIA+ community and increasing success rates of in-vitro fertilization (IVF) and related ART procedures are driving market revenue growth.
Infertility can be treated using ART. ART assists in treating infertility by providing a variety of procedures a patient can choose from according to the patient’s need and their medical history. The most popular and efficient type of ART is in-vitro fertilization (IVF). Donor eggs, donor sperm, or frozen embryos are some popular services availed by patients in ART. Surrogacy is a major driving factor for market growth as more people are moving past the social stigma associated with it and focusing on the benefits that it provides.
Multiple gestation or multiple pregnancies is a major restrain for the ART market as it is considered a great risk to the patient and the infant’s health. The Centers for Disease Control (CDC) reported that while ART accounts for 17% of twins born to couples, the risk of multiple pregnancies while undergoing ART procedures is 27 times more than those who conceive naturally. This factor is restraining market growth.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1402
Some Key Highlights from the Report
- In February 2021, TMRW Life Sciences announced the release of the world’s first automated Cryo specimen management solution for eggs and embryos used in IVF procedures. The TMRW platform has been launched at a number of fertility clinics across the US, allowing for the management of millions of embryos and eggs used in modern IVF.
- Egg/embryo banking segment accounted for a significantly large revenue share in 2021. Women are born with a limited number of eggs that they can have and as they age their eggs decrease. Women who are bound by tight work schedules and cannot afford the time to bear a child due to their career or any other reason but still want to be a mother at some point of their life prefer egg/embryo banking where their eggs are frozen and stored safely under monitored conditions. They can use their stored eggs to conceive a child at their preferred time.
- Frozen embryo replacement (FER) segment accounted for a significantly large revenue share in 2021. Improvements in embryo freezing, notably the vitrification procedure, have increased the frequency of delayed frozen embryo transfers. The advantages of delayed embryo transfer include lowering the pregnancy risks associated with fresh embryo transfer IVF cycles, allowing the uterus environment to restore to normal after egg harvesting, and allowing for genetic screening.
- Market in North America is expected to grow at a steady rate over the forecast period. This is owing to increased public awareness regarding various fertility alternatives, government backing for in-vitro fertilization to counter the social stigma surrounding ART, and other technological and procedural advancements.
- Companies profiled in the global market report includes Cosmos Biomedical Ltd., Microm UK Ltd., CooperSurgical Fertility Solutions, FUJIFILM Irvine Scientific, Cryolab Ltd., Parallabs Ltd., European Sperm Bank, OvaScience, Inc., Bloom IVF, and Ferring Pharmaceuticals.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market
For this study, Reports and Data has segmented the ART market based on type, procedure, procedure technology, end-use, and region:
Type Technology Outlook (Revenue, USD Billion; 2019–2030)
- Artificial Insemination
- Surrogacy
- Ovulation Induction
- Others
Procedure Outlook (Revenue, USD Billion; 2019–2030)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Embryo/Egg Banking
- Others
Procedure Technology Outlook (Revenue, USD Billion; 2019–2030)
- In-Vitro Fertilization
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without ICSI
- Artificial Insemination-Intrauterine Insemination
- Frozen Embryo Replacement
- Others
End-use Outlook (Revenue, USD Billion; 2019–2030)
- Fertility Clinics
- Hospitals
- Clinical Research
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/1402
Regional Outlook (Revenue, USD Billion; 2019–2030)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1402
Some points on how the report benefits stakeholders:
- The reports include historical (2019–2020) and forecast (2021–2030) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Vacutainer Market By Product Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, and Others), By Material (Glass, Plastic), By End-Use (Diagnostic Centers, Healthcare Centers, Research and Development Centers), And By Region Forecast to 2028
Plasma Fractionation Market Size, Share And Industry Analysis By Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), By End-Use (Hospital, Clinical Research Lab, and Academic Institutes), By Application (Hematology, Haemato-Oncology, Rheumatology, Immunology, and Neurology) and By Region Forecast to 2028
Hepatitis A Vaccine Market Size, Share And Industry Analysis By Product Type (Live Attenuated Vaccine and Inactivated Vaccine), By Industry (Government Institution and Private Sector), By Channel (Direct Sales and Distributor), and By Region Forecast to 2028
Heat and Moisture Exchanger Market , By Product (Heated Wire Humidifiers, Non-heated Wire Humidifiers, High-efficiency Particulate Absorbing Filters, Straight HMEs, Others), By Device Type (Disposable Heat and Moisture Exchangers, Reusable Heat and Moisture Exchangers), By Application (Respiratory Care, Pediatric Care, Neonatal Care, Others), By End-use, and By Region, Forecast to 2028
Otitis Drug Market , By Disease Type (Acute Otitis Media, Otitis Media with Effusion, Chronic Otitis Media with Effusion), By Drug Types (Antibiotics, Non-steroidal Anti-inflammatory, Analgesic, Anaesthetic, Others), By End-User Type (Hospitals, Homecare, Specialty Clinics, Others), By Treatment Type (Medication and Surgery), and By Region Forecast to 2028.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-assisted-reproductive-technology-art-market